Safety and efficacy of CT-guided transforaminal cervical epidural steroid injections using a posterior approach

John T. Wald, Timothy Maus, J. R. Geske, Rickey E. Carter, F. E. Diehn, Timothy J Kaufmann, J. M. Morris, Naveen S Murthy, K. R. Thielen

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Image-guided cervical transforaminal epidural injections play an important role in the management of cervical radicular pain syndromes. The safety and efficacy of these injections via an anterolateral approach has been well-studied. The goal of this retrospective review was to determine the safety and efficacy of CT-guided transforaminal epidural injections by using a posterior approach. MATERIALS AND METHODS: Retrospective review of patient records was used to define VNPS and RMDI of patients undergoing CT-guided transforaminal cervical epidural injections between 2006 and 2010. Pain scores were recorded preprocedure, immediately postprocedure, at 2 weeks, and at 2 months. The RMDI was recorded preprocedure, at 2 weeks, and at 2 months. Data analysis of 247 patients was completed. Differences in VNPS scores and the RMDI were then compared on the basis of a CT-guided approach (anterolateral versus posterior). RESULTS: There was no statistical difference in the degree of pain relief and improvement in the RMDI between the CT-guided transforaminal anterolateral approach and the posterior approach at 2 weeks and at 2 months. Both groups demonstrated a statistically significant improvement in pain scores and the RMDI. Approximately 35% of patients in both groups demonstrated >50% pain relief at 2 months. There were no serious complications in either group. CONCLUSIONS: CT-guided transforaminal cervical epidural injections by using a posterior approach are safe and effective.

Original languageEnglish (US)
Pages (from-to)415-419
Number of pages5
JournalAmerican Journal of Neuroradiology
Volume33
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Epidural Injections
Steroids
Safety
Pain
Neck Pain
Injections

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging

Cite this

Safety and efficacy of CT-guided transforaminal cervical epidural steroid injections using a posterior approach. / Wald, John T.; Maus, Timothy; Geske, J. R.; Carter, Rickey E.; Diehn, F. E.; Kaufmann, Timothy J; Morris, J. M.; Murthy, Naveen S; Thielen, K. R.

In: American Journal of Neuroradiology, Vol. 33, No. 3, 03.2012, p. 415-419.

Research output: Contribution to journalArticle

@article{d4a584ceb6784227b4a74c2c3cdca554,
title = "Safety and efficacy of CT-guided transforaminal cervical epidural steroid injections using a posterior approach",
abstract = "BACKGROUND AND PURPOSE: Image-guided cervical transforaminal epidural injections play an important role in the management of cervical radicular pain syndromes. The safety and efficacy of these injections via an anterolateral approach has been well-studied. The goal of this retrospective review was to determine the safety and efficacy of CT-guided transforaminal epidural injections by using a posterior approach. MATERIALS AND METHODS: Retrospective review of patient records was used to define VNPS and RMDI of patients undergoing CT-guided transforaminal cervical epidural injections between 2006 and 2010. Pain scores were recorded preprocedure, immediately postprocedure, at 2 weeks, and at 2 months. The RMDI was recorded preprocedure, at 2 weeks, and at 2 months. Data analysis of 247 patients was completed. Differences in VNPS scores and the RMDI were then compared on the basis of a CT-guided approach (anterolateral versus posterior). RESULTS: There was no statistical difference in the degree of pain relief and improvement in the RMDI between the CT-guided transforaminal anterolateral approach and the posterior approach at 2 weeks and at 2 months. Both groups demonstrated a statistically significant improvement in pain scores and the RMDI. Approximately 35{\%} of patients in both groups demonstrated >50{\%} pain relief at 2 months. There were no serious complications in either group. CONCLUSIONS: CT-guided transforaminal cervical epidural injections by using a posterior approach are safe and effective.",
author = "Wald, {John T.} and Timothy Maus and Geske, {J. R.} and Carter, {Rickey E.} and Diehn, {F. E.} and Kaufmann, {Timothy J} and Morris, {J. M.} and Murthy, {Naveen S} and Thielen, {K. R.}",
year = "2012",
month = "3",
doi = "10.3174/ajnr.A2835",
language = "English (US)",
volume = "33",
pages = "415--419",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "3",

}

TY - JOUR

T1 - Safety and efficacy of CT-guided transforaminal cervical epidural steroid injections using a posterior approach

AU - Wald, John T.

AU - Maus, Timothy

AU - Geske, J. R.

AU - Carter, Rickey E.

AU - Diehn, F. E.

AU - Kaufmann, Timothy J

AU - Morris, J. M.

AU - Murthy, Naveen S

AU - Thielen, K. R.

PY - 2012/3

Y1 - 2012/3

N2 - BACKGROUND AND PURPOSE: Image-guided cervical transforaminal epidural injections play an important role in the management of cervical radicular pain syndromes. The safety and efficacy of these injections via an anterolateral approach has been well-studied. The goal of this retrospective review was to determine the safety and efficacy of CT-guided transforaminal epidural injections by using a posterior approach. MATERIALS AND METHODS: Retrospective review of patient records was used to define VNPS and RMDI of patients undergoing CT-guided transforaminal cervical epidural injections between 2006 and 2010. Pain scores were recorded preprocedure, immediately postprocedure, at 2 weeks, and at 2 months. The RMDI was recorded preprocedure, at 2 weeks, and at 2 months. Data analysis of 247 patients was completed. Differences in VNPS scores and the RMDI were then compared on the basis of a CT-guided approach (anterolateral versus posterior). RESULTS: There was no statistical difference in the degree of pain relief and improvement in the RMDI between the CT-guided transforaminal anterolateral approach and the posterior approach at 2 weeks and at 2 months. Both groups demonstrated a statistically significant improvement in pain scores and the RMDI. Approximately 35% of patients in both groups demonstrated >50% pain relief at 2 months. There were no serious complications in either group. CONCLUSIONS: CT-guided transforaminal cervical epidural injections by using a posterior approach are safe and effective.

AB - BACKGROUND AND PURPOSE: Image-guided cervical transforaminal epidural injections play an important role in the management of cervical radicular pain syndromes. The safety and efficacy of these injections via an anterolateral approach has been well-studied. The goal of this retrospective review was to determine the safety and efficacy of CT-guided transforaminal epidural injections by using a posterior approach. MATERIALS AND METHODS: Retrospective review of patient records was used to define VNPS and RMDI of patients undergoing CT-guided transforaminal cervical epidural injections between 2006 and 2010. Pain scores were recorded preprocedure, immediately postprocedure, at 2 weeks, and at 2 months. The RMDI was recorded preprocedure, at 2 weeks, and at 2 months. Data analysis of 247 patients was completed. Differences in VNPS scores and the RMDI were then compared on the basis of a CT-guided approach (anterolateral versus posterior). RESULTS: There was no statistical difference in the degree of pain relief and improvement in the RMDI between the CT-guided transforaminal anterolateral approach and the posterior approach at 2 weeks and at 2 months. Both groups demonstrated a statistically significant improvement in pain scores and the RMDI. Approximately 35% of patients in both groups demonstrated >50% pain relief at 2 months. There were no serious complications in either group. CONCLUSIONS: CT-guided transforaminal cervical epidural injections by using a posterior approach are safe and effective.

UR - http://www.scopus.com/inward/record.url?scp=84858679654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858679654&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A2835

DO - 10.3174/ajnr.A2835

M3 - Article

C2 - 22207298

AN - SCOPUS:84858679654

VL - 33

SP - 415

EP - 419

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 3

ER -